The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential
Abstract
Energy homeostasis during fasting or prolonged exercise depends on mitochondrial fatty acid oxidation (FAO). This pathway is crucial in many tissues with high energy demand and its disruption results in inborn FAO deficiencies. More than 15 FAO genetic defects have been currently described, and pathological variants described in circumpolar populations provide insights into its critical role in metabolism. The use of fatty acids as energy requires more than 2 dozen enzymes and transport proteins, which are involved in the activation and transport of fatty acids into the mitochondria. As the key rate-limiting enzyme of FAO, carnitine palmitoyltransferase I (CPT1) regulates FAO and facilitates adaptation to the environment, both in health and in disease, including cancer. The CPT1 family of proteins contains 3 isoforms: CPT1A, CPT1B, and CPT1C. This review focuses on CPT1A, the liver isoform that catalyzes the rate-limiting step of converting acyl-coenzyme As into acyl-carnitines, which can then cross membranes to get into the mitochondria. The regulation of CPT1A is complex and has several layers that involve genetic, epigenetic, physiological, and nutritional modulators. It is ubiquitously expressed in the body and associated with dire consequences linked with genetic mutations, metabolic disorders, and cancers. This makes CPT1A an attractive target for therapeutic interventions. This review discusses our current understanding of CPT1A expression, its role in heath and disease, and the potential for therapeutic opportunities targeting this enzyme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., & Wahli, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6223 · Cited by 1,649
The Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular Analysis
McGarry, J. D., & Brown, N. F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00001.x · Cited by 1,616
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
Finck, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27794 · Cited by 1,432
Leone, T. C., Weinheimer, C. J., & Kelly, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7473 · Cited by 943
The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic Disorders
Houten, S. M., Violante, S., Ventura, F. V., & Wanders, R. J. A. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105045 · Cited by 920
Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2
Abu-Elheiga, L., Matzuk, M. M., Abo-Hashema, K. A. H., & Wakil, S. J. (2001) · Science · doi:10.1126/science.1056843 · Cited by 903
A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis.
McGarry, J. D., Mannaerts, G. P., & Foster, D. W. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108764 · Cited by 736
Samudio, I., Harmancey, R., Fiegl, M., Kantarjian, H., Konopleva, M., Korchin, B., Kaluarachchi, K., Bornmann, W., Duvvuri, S., Taegtmeyer, H., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38942 · Cited by 709
Malonyl-CoA, fuel sensing, and insulin resistance
Ruderman, N. B., Saha, A. K., Vavvas, D., & Witters, L. A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.1.e1 · Cited by 650
Fatty acid carbon is essential for dNTP synthesis in endothelial cells
Schoors, S., Bruning, U., Missiaen, R., Queiroz, K. C. S., Borgers, G., Elia, I., Zecchin, A., Cantelmo, A. R., Christen, S., Goveia, J., et al. (2015) · Nature · doi:10.1038/nature14362 · Cited by 646 · cited 1×
“Besides the extreme phenotype of the CPT1A deficiency, attenuated expression of CPT1A also compromises the ability of cells to make aspartate, a nucleotide precursor to make DNA, and effect that has been observed in human umbilical venous endothelial cells with impaired proliferation (26).”
BackgroundCarnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects
BONNEFONT, J. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.06.004 · Cited by 637
Increased lipogenesis in cancer cells: new players, novel targets
Swinnen, J. V., Brusselmans, K., & Verhoeven, G. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232894.28674.30 · Cited by 610
McGarry, J. D., Mills, S. E., Long, C. S., & Foster, D. W. (1983) · Biochemical Journal · doi:10.1042/bj2140021 · Cited by 556
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer
Qu, Q., Zeng, F., Liu, X., Wang, Q. J., & Deng, F. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.132 · Cited by 545
Kunau, W. (1995) · Progress in Lipid Research · doi:10.1016/0163-7827(95)00011-9 · Cited by 510
Brandt, J. M., Djouadi, F., & Kelly, D. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23786 · Cited by 456
Medes, G., Thomas, A. J., & Weinhouse, S. (1953) · PubMed · Cited by 405
CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis
Wang, Y.-N., Zeng, Z.-L., Lu, J., Wang, Y., Liu, Z.-X., He, M.-M., Zhao, Q., Wang, Z.-X., Li, T., Lu, Y.-X., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0384-z · Cited by 380
Regulation of ketogenesis and the renaissance of carnitine palmitoyltransferase
McGarry, J. D., Woeltje, K. F., Kuwajima, M., & Foster, D. W. (1989) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610050305 · Cited by 357
Corbet, C., Pinto, A., Martherus, R., Santiago de Jesus, J. P., Polet, F., & Feron, O. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.07.003 · Cited by 336
Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle
Knottnerus, S. J. G., Bleeker, J. C., Wüst, R. C. I., Ferdinandusse, S., IJlst, L., Wijburg, F. A., Wanders, R. J. A., Visser, G., & Houtkooper, R. H. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-018-9448-1 · Cited by 331
Park, J. H., Vithayathil, S., Kumar, S., Sung, P.-L., Dobrolecki, L. E., Putluri, V., Bhat, V. B., Bhowmik, S. K., Gupta, V., Arora, K., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.004 · Cited by 313
Lipid Catabolism via CPT1 as a Therapeutic Target for Prostate Cancer
Schlaepfer, I. R., Rider, L., Rodrigues, L. U., Gijón, M. A., Pac, C. T., Romero, L., Cimic, A., Sirintrapun, S. J., Glodé, L. M., Eckel, R. H., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0183 · Cited by 304
Self-citationPharmacokinetics of L-Carnitine
Evans, A. M., & Fornasini, G. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342110-00002 · Cited by 301
Holubarsch, C. J. F., Rohrbach, M., Karrasch, M., Boehm, E., Polonski, L., Ponikowski, P., & Rhein, S. (2007) · Clinical Science · doi:10.1042/cs20060307 · Cited by 287
A Novel Brain-Expressed Protein Related to Carnitine Palmitoyltransferase I
Price, N. T., van der Leij, F. R., Jackson, V. N., Corstorphine, C. G., Thomson, R., Sorensen, A., & Zammit, V. A. (2002) · Genomics · doi:10.1006/geno.2002.6845 · Cited by 270
Role of carnitine in hepatic ketogenesis.
McGarry, J. D., Robles-Valdes, C., & Foster, D. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.11.4385 · Cited by 260
Lee, K., Kerner, J., & Hoppel, C. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228692 · Cited by 254
The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis
Wolfgang, M. J., Kurama, T., Dai, Y., Suwa, A., Asaumi, M., Matsumoto, S.-I., Cha, S. H., Shimokawa, T., & Lane, M. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602205103 · Cited by 251
Chalmers, R. A., Roe, C. R., Stacey, T. E., & Hoppel, C. L. (1984) · Pediatric Research · doi:10.1203/00006450-198412000-00021 · Cited by 248
Ricciardi, M. R., Mirabilii, S., Allegretti, M., Licchetta, R., Calarco, A., Torrisi, M. R., Foà, R., Nicolai, R., Peluso, G., & Tafuri, A. (2015) · Blood · doi:10.1182/blood-2014-12-617498 · Cited by 222
Song, S., Attia, R. R., Connaughton, S., Niesen, M. I., Ness, G. C., Elam, M. B., Hori, R. T., Cook, G. A., & Park, E. A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.05.019 · Cited by 215
Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone
Kennedy, J. A., Unger, S. A., & Horowitz, J. D. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00204-3 · Cited by 209
Combined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial disease
Nsiah-Sefaa, A., & McKenzie, M. (2016) · Bioscience Reports · doi:10.1042/bsr20150295 · Cited by 193
Sierra, A. Y., Gratacós, E., Carrasco, P., Clotet, J., Ureña, J., Serra, D., Asins, G., Hegardt, F. G., & Casals, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707965200 · Cited by 190
Cancer Metabolism and the Evasion of Apoptotic Cell Death
Sharma, A., Boise, L., & Shanmugam, M. (2019) · Cancers · doi:10.3390/cancers11081144 · Cited by 185
Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency
Bougnères, P.-F., Saudubray, J.-M., Marsac, C., Bernard, O., Odièvre, M., & Girard, J. (1981) · The Journal of Pediatrics · doi:10.1016/s0022-3476(81)80834-7 · Cited by 180
Lefort, N., Glancy, B., Bowen, B., Willis, W. T., Bailowitz, Z., De Filippis, E. A., Brophy, C., Meyer, C., Højlund, K., Yi, Z., et al. (2010) · Diabetes · doi:10.2337/db10-0174 · Cited by 174
Malonyl-coa and carnitine in regulation of fat oxidation in human skeletal muscle during exercise
Roepstorff, C., Halberg, N., Hillig, T., Saha, A. K., Ruderman, N. B., Wojtaszewski, J. F. P., Richter, E. A., & Kiens, B. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00379.2004 · Cited by 173
Ashrafian, H., Horowitz, J. D., & Frenneaux, M. P. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00006.x · Cited by 173
Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states.
Heimberg, M., Olubadewo, J., & Wilcox, H. (1985) · Endocrine reviews · doi:10.1210/edrv-6-4-590 · Cited by 165
When fats commit crimes: fatty acid metabolism, cancer stemness and therapeutic resistance
Kuo, C., & Ann, D. K. (2018) · 癌症:英文版 · doi:10.1186/s40880-018-0317-9 · Cited by 159
CPT1A‐mediated succinylation of S100A10 increases human gastric cancer invasion
Wang, C., Zhang, C., Li, X., Shen, J., Xu, Y., Shi, H., Mu, X., Pan, J.-S., Zhao, T., Li, M., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13920 · Cited by 136
Topology of carnitine palmitoyltransferase I in the mitochondrial outer membrane.
Fraser, F., Corstorphine, C. G., & Zammit, V. (1997) · Biochemical Journal · doi:10.1042/bj3230711 · Cited by 135
Suburu, J., & Chen, Y. Q. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.03.003 · Cited by 135
Lipid Metabolism and Endocrine Resistance in Prostate Cancer, and New Opportunities for Therapy
Stoykova, G. E., & Schlaepfer, I. R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112626 · Cited by 129
Self-citationCancer Metabolism Drives a Stromal Regenerative Response
Schwörer, S., Vardhana, S. A., & Thompson, C. B. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.015 · Cited by 128
Park, E. A., Mynatt, R. L., Cook, G. A., & Kashfi, K. (1995) · Biochemical Journal · doi:10.1042/bj3100853 · Cited by 122
Yamazaki, N., Shinohara, Y., Shima, A., Yamanaka, Y., & Terada, H. (1996) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(96)00069-3 · Cited by 119
Shao, H., Mohamed, E. M., Xu, G.-Y. G., Waters, M., Jing, K., Ma, Y., Zhang, Y., Spiegel, S., Idowu, M., & Fang, X.-J. (2015) · OncoTarget · doi:10.18632/oncotarget.6757 · Cited by 119
Ceccarelli, S. M., Chomienne, O., Gubler, M., & Arduini, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100809g · Cited by 118
Inhibition of Fatty Acid Metabolism Reduces Human Myeloma Cells Proliferation
Tirado-Vélez, J. M., Joumady, I., Sáez-Benito, A., Cózar‐Castellano, I., & Perdomo, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046484 · Cited by 115
Pacilli, A., Calienni, M., Margarucci, S., D’Apolito, M., Petillo, O., Rocchi, L., Pasquinelli, G., Nicolai, R., Koverech, A., Calvani, M., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt030 · Cited by 114
Schlaepfer, I. R., Nambiar, D. K., Ramteke, A. S., Kumar, R., Dhar, D., Agarwal, C., Bergman, B. C., Graner, M. W., MARONI, P. D., Singh, R. P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4479 · Cited by 112
Self-citationHypothalamic Ceramide Levels Regulated by CPT1C Mediate the Orexigenic Effect of Ghrelin
Ramírez, S., Martins, L., Jacas, J., Carrasco, P., Pozo, M., Clotet, J., Serra, D., Hegardt, F. G., Diéguez, C., López, M., et al. (2013) · Diabetes · doi:10.2337/db12-1451 · Cited by 111
In utero exposure to a maternal high-fat diet alters the epigenetic histone code in a murine model
Suter, M., Ma, J., Vuguin, P. M., Hartil, K., Fiallo, A., Harris, R. A., Charron, M. J., & Aagaard, K. M. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.01.045 · Cited by 110
Brown, N. F., MULLUR, R. S., Subramanian, I. M., Esser, V., Bennett, M. J., Saudubray, J., Feigenbaum, A. S. J., Kobari, J. A., MacLeod, P., McGarry, J., et al. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31604-7 · Cited by 108
Dietary L-carnitine Stimulates Carnitine Acyltransferases in the Liver of Aged Rats
Karlic, H., Lohninger, S., Koeck, T., & Lohninger, A. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000208 · Cited by 107
Deep, G., & Schlaepfer, I. R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071061 · Cited by 103
Self-citationPeroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient
Violante, S. N., IJlst, L., Brinke, H. T., Koster, J., de Almeida, I. T., Wanders, R. J. A., Ventura, F. V., & Houten, S. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.06.007 · Cited by 100
Mitochondrial localization, import, and mitochondrial function of the androgen receptor
Bajpai, P., Koc, E., Sonpavde, G., Singh, R., & Singh, K. K. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006727 · Cited by 99 · cited 1×
“Concomitantly, how AR signaling modulates CPT1A activity remains to be elucidated, but it is possible that the increase in AR signaling is a compensatory response to decreased CPT1A in the mitochondria, where AR has been recently found (52).”
BackgroundConti, R., Mannucci, E., Pessotto, P., Tassoni, E., Carminati, P., Giannessi, F., & Arduini, A. (2011) · Diabetes · doi:10.2337/db10-0346 · Cited by 98
Structural insight into function and regulation of carnitine palmitoyltransferase
Rufer, A. C., Thoma, R., & Hennig, M. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0035-1 · Cited by 98
Methylation at CPT1A locus is associated with lipoprotein subfraction profiles
Wood, A. C., Aslibekyan, S. W., Absher, D., Hopkins, P. N., Sha, J., Tsai, M. Y., Tiwari, H. K., Waite, L. L., Zhi, D., & Arnett, D. K. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m048504 · Cited by 97
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade
Flaig, T., Salzmann-Sullivan, M., Su, L.-J., Zhang, Z.-Y., Joshi, M., Gijón, M., Kim, J., Arcaroli, J., van Bokhoven, A., Lucia, M., et al. (2017) · OncoTarget · doi:10.18632/oncotarget.17359 · Cited by 97
Self-citationNapal, L., Marrero, P. F., & Haro, D. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.097 · Cited by 95
Cancer patterns in Inuit populations
Friborg, J., & Melbye, M. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70231-6 · Cited by 94
Regulation of liver carnitine palmitoyltransferase I gene expression by hormones and fatty acids
Louet, J., May, C. L., Pégorier, J. P., Decaux, J., & Girard, J. R. (2001) · Biochemical Society Transactions · doi:10.1042/0300-5127:0290310 · Cited by 93
Kennedy, J. A., Kiosoglous, A. J., Murphy, G. A., Pelle, M. A., & Horowitz, J. D. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200012000-00016 · Cited by 89
Akkaoui, M., Cohen, I., Esnous, C., Lenoir, V., Sournac, M., Girard, J. R., & Prip‐Buus, C. (2009) · Biochemical Journal · doi:10.1042/bj20081932 · Cited by 86
Fatty acid oxidation is associated with proliferation and prognosis in breast and other cancers
Aiderus, A., Black, M. A., & Dunbier, A. K. (2018) · BMC Cancer · doi:10.1186/s12885-018-4626-9 · Cited by 86
Ohashi, K., Munetsuna, E., Yamada, H., Ando, Y., Yamazaki, M., Taromaru, N., Nagura, A., Ishikawa, H., Suzuki, K. A. O., Teradaira, R., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.134 · Cited by 83
Britton, C. H., Mackey, D. W., Esser, V., Foster, D. W., Burns, D. K., Yarnall, D. P., Froguel, P., & McGarry, J. (1997) · Genomics · doi:10.1006/geno.1996.4539 · Cited by 82
Greenberg, C. R., Dilling, L. A., Thompson, G. R., Seargeant, L. E., Haworth, J. C., Phillips, S., Chan, A., Vallance, H. D., Waters, P. J., Sinclair, G. B., et al. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2008.12.018 · Cited by 80
Lemas, D. J., Wiener, H. W., O’Brien, D. M., Hopkins, S. E., Stanhope, K. L., Havel, P. J., Allison, D. B., Fernández, J. R., Tiwari, H. K., & Boyer, B. B. (2011) · Journal of Lipid Research · doi:10.1194/jlr.p018952 · Cited by 79
Carrasco, P., Sahún, I., McDonald, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337493 · Cited by 78
Giannessi, F., Pessotto, P., Tassoni, E., Chiodi, P., Conti, R., de Angelis, F., Dell'uomo, N., Catini, R., Deias, R., Tinti, M., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020979u · Cited by 77
Schlaepfer, I. R., Glodé, L. M., Hitz, C. A., Pac, C. T., Boyle, K. E., MARONI, P. D., Deep, G., Agarwal, R., Lucia, S. M., Cramer, S. D., et al. (2015) · Molecular Imaging and Biology · doi:10.1007/s11307-014-0814-4 · Cited by 74
Self-citationNonstatin Therapies for Management of Dyslipidemia: A Review
Sando, K. R., & Knight, M. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.09.001 · Cited by 73
Distler, A. M., Kerner, J., & Hoppel, C. L. (2007) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.03.012 · Cited by 71
New Strategies in Prostate Cancer: Targeting Lipogenic Pathways and the Energy Sensor AMPK
Zadra, G., Priolo, C., Patnaik, A., & Loda, M. F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1955 · Cited by 70
Mutation in CPT1C Associated With Pure Autosomal Dominant Spastic Paraplegia
Rinaldi, C., Schmidt, T., Situ, A. J., Johnson, J. O., Lee, P. R., Chen, K.-L., Bott, L. C., Fadó, R., Harmison, G., Parodi, S., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.4769 · Cited by 69
Phosphorylation of Rat Liver Mitochondrial Carnitine Palmitoyltransferase-I
Kerner, J., Distler, A. M., Minkler, P. E., Parland, W., Peterman, S. M., & Hoppel, C. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406570200 · Cited by 69
Rajakumar, C., Ban, M. R., Cao, H., Young, T. K., Bjerregaard, P., & Hegele, R. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p900001-jlr200 · Cited by 69
Functional and Structural Basis of Carnitine Palmitoyltransferase 1A Deficiency*
Gobin, S., Thuillier, L., Jogl, G., Faye, A., Tong, L., Chi, M., Bonnefont, J., Girard, J., & Prip-Buus, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m310130200 · Cited by 68
López-Viñas, E., Bentebibel, A., Gurunathan, C., Morillas, M., de Arriaga, D., Serra, D., Asins, G., Hegardt, F., & Gómez-Puertas, P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700885200 · Cited by 67
Salehzadeh, F., Rune, A., Osler, M., & Al-Khalili, L. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0497 · Cited by 66
Epigenetic regulation of carnitine palmitoyltransferase 1 (Cpt1a) by high fat diet
Moody, L., Xu, G. B., Chen, H., & Pan, Y. (2018) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2018.12.009 · Cited by 66
Der Abbau aromatischer Fettsäuren im Tierkörper
Knoop, F. (1904) · Medical Entomology and Zoology · Cited by 62
Zhou, Z., Zhou, J., & Du, Y. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.011056 · Cited by 62
van Weeghel, M., Abdurrachim, D., Nederlof, R., Argmann, C., Houtkooper, R. H., Hagen, J., Nabben, M., Denis, S. W., Čiapaitė, J., Kolwicz, S. C., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy089 · Cited by 59
Gonthier, K., Poluri, R. T. K., & Audet-Walsh, É. (2019) · Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.04.016 · Cited by 55
Substituted 2-oxiranecarboxylic acids: a new group of candidate hypoglycaemic drugs.
Selby, P. L., & Sherratt, H. (1989) · TIPS - Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90049-7 · Cited by 54
Prip-Buus, C., Thuillier, L., Abadi, N., Prasad, C., Dilling, L., Klasing, J., Demaugre, F., Greenberg, C. R., Haworth, J. C., Droin, V., et al. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3176 · Cited by 54
Morillas, M., Gómez‐Puertas, P., Roca, R., Serra, D., Asins, G., Valencia, A., & Hegardt, F. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106920200 · Cited by 53
Shin, E. S., Cho, S. Y., Lee, E. H., Lee, S. J., Chang, I., & Lee, T. R. (2005) · European Journal of Nutrition · doi:10.1007/s00394-005-0576-5 · Cited by 51
Gobin, S., Bonnefont, J., Prip-Buus, C., Mugnier, C., Ferrec, M., Demaugre, F., Saudubray, J., Rostane, H., Djouadi, F., Wilcox, W., et al. (2002) · Human Genetics · doi:10.1007/s00439-002-0752-0 · Cited by 51
Functional Studies of Yeast-Expressed Human Heart Muscle Carnitine Palmitoyltransferase I
Zhu, H., Shi, J., de Vries, Y., Arvidson, D. N., Cregg, J. M., & Woldegiorgis, G. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0314 · Cited by 50
CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling.
Xiong, Y., Liu, Z.-M., Zhao, X., Ruan, S.-N., Zhang, X.-M., Wang, S., & Huang, T. (2018) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2018.05.112 · Cited by 48
Maples, J. M., Brault, J. J., Witczak, C. A., Park, S., Hubal, M. J., Weber, T. M., Houmard, J. A., & Shewchuk, B. M. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00505.2014 · Cited by 47
Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes
Galicia-Vázquez, G., & Aloyz, R. S. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00411 · Cited by 47
CPT1A Supports Castration-Resistant Prostate Cancer in Androgen-Deprived Conditions
Joshi, M., Stoykova, G. E., Salzmann‐Sullivan, M., Dzieciątkowska, M., Liebman, L. N., Deep, G., & Schlaepfer, I. R. (2019) · Cells · doi:10.3390/cells8101115 · Cited by 44
Self-citationRodríguez‐Rodríguez, R., Miralpeix, C., Fosch, A., Pozo, M., Calderón‐Domínguez, M., Perpiñà, X., Vellvehi, M., López, M., Herrero, L., Serra, D., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.10.010 · Cited by 42
Faye, A., Esnous, C., Price, N. T., Onfray, M. A., Girard, J. R., & Prip‐Buus, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705418200 · Cited by 41
STEFFEN, M. L., Harrison, W. R., Elder, F. F. B., Cook, G. A., & Park, E. A. (1999) · Biochemical Journal · doi:10.1042/bj3400425 · Cited by 39
Faye, A., Borthwick, K., Esnous, C., Price, N. T., Gobin, S., Jackson, V. N., Zammit, V. A., Girard, J. R., & Prip‐Buus, C. (2005) · Biochemical Journal · doi:10.1042/bj20041533 · Cited by 38
Maarman, G. J., Marais, E., Lochner, A., & Toit, E. F. D. (2012) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-012-6377-1 · Cited by 38
Independent Effects of Testosterone on Lipid Oxidation and VLDL-TG Production
Høst, C., Gormsen, L. C., Christensen, B., Jessen, N., Hougaard, D. M., Christiansen, J. S., Pedersen, S. B., Jensen, M. D., Nielsen, S., & Gravholt, C. H. (2013) · Diabetes · doi:10.2337/db12-0440 · Cited by 37
Kashfi, K., Mynatt, R. L., & Cook, G. A. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90259-3 · Cited by 37
Rao, J. N., Warren, G. Z. L., Estolt-Povedano, S., Zammit, V., & Ulmer, T. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.306951 · Cited by 35
Gessner, B., Gillingham, M., Birch, S., Wood, T., & Koeller, D. (2010) · Pediatrics · doi:10.1542/peds.2010-0687 · Cited by 34
Sadana, P., Zhang, Y., Song, S., Cook, G. A., Elam, M. B., & Park, E. A. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.11.012 · Cited by 32
Wang, D., Harrison, W., Buja, L. M., Elder, F. F. B., & McMillin, J. B. (1998) · Genomics · doi:10.1006/geno.1997.5184 · Cited by 30
Mørkholt, A. S., Trabjerg, M. S., Oklinski, M. K., Bolther, L., Kroese, L. J., Pritchard, C. E. J., Huijbers, I. J., & Nieland, J. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-49868-6 · Cited by 26
Dai, J., Zhu, H.-F., Shi, J.-Y., & Woldegiorgis, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002118200 · Cited by 25
Expression analysis of two mutations in carnitine palmitoyltransferase IA deficiency
Ogawa, E., Kanazawa, M., Yamamoto, S., Ohtsuka, S., Ogawa, A., Ohtake, A., Takayanagi, M., & Kohno, Y. (2002) · Journal of Human Genetics · doi:10.1007/s100380200047 · Cited by 22
Carnitine palmitoyltransferase 1A P479L and infant death: policy implications of emerging data
Fohner, A. E., Garrison, N. A., Austin, M. A., & Burke, W. (2017) · Genetics in Medicine · doi:10.1038/gim.2016.202 · Cited by 19
Suter, M., Ma, J., Vuguin, P. M., Hartil, K., Fiallo, A., Charron, M. J., & Aagaard, K. M. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.10.097 · Cited by 13
Health effects of the CPT1A P479L variant: responsible public health policy
Koeller, D. M., Hirschfeld, M. J., Birch, S., Wood, T., Morisse, R., Anckner, S., & Gessner, B. D. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.116 · Cited by 9
Cited by
NADPH homeostasis in cancer: functions, mechanisms and therapeutic implications
Ju, H.-Q., Lin, J.-F., Tian, T., Xie, D., & Xu, R.-H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00326-0 · Cited by 581
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
Hu, T., Liu, C.-H., Lei, M., Zeng, Q., Li, L., Tang, H., & Zhang, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01954-6 · Cited by 383
Miguel, V., Tituaña, J., Herrero, J. I., Herrero, L., Serra, D., Cuevas, P., Barbas, C., Puyol, D. R., Márquez-Expósito, L., Ruiz-Ortega, M., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci140695 · Cited by 344
Wu, D., Spencer, C. B., Ortoga, L., Zhang, H., & Miao, C. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103194 · Cited by 310
ACSL family: The regulatory mechanisms and therapeutic implications in cancer
Quan, J., Bode, A. M., & Luo, X. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174397 · Cited by 306
Metadata
- Authors
- Schlaepfer, I. R., & Joshi, M.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2020-01-04
- Volume
- 161
- Issue
- 2
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2997840987
- Cited by
- 732
- References
- 120
- FWCI
- 40.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.